Anisole

Anisole

SCHEMBL5897057

COc1ccccc1.OCCOCCO

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA4 P22748 1/20 0.61
ALDH1A1 P00352 4/20 0.56
RECQL P46063 1/20 0.56
LTA4H P09960 2/20 0.52
DRD2 P14416 1/20 0.46
DRD4 P21917 1/20 0.46
DRD3 P35462 1/20 0.46
TSHR P16473 2/20 0.45
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44
MAPK1 P28482 1/20 0.43
MEN1 O00255 5/20 0.42
KMT2A Q03164 5/20 0.42
NPC1 O15118 2/20 0.42
MAPT P10636 2/20 0.42
RAB9A P51151 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butoxyethanol SCHEMBL28099299 0.89 TSHR (0.59) CA4ALDH1A1RECQLLTA4HDRD2
Anisole SCHEMBL23928028 0.88 CA4 (0.47) CA4ALDH1A1RECQLLTA4HDRD2
Anisole SCHEMBL213737 0.86 CA4 (0.74) CA4ALDH1A1RECQLLTA4HDRD2
Anisole SCHEMBL28157536 0.86 CA4 (0.74) CA4ALDH1A1RECQLLTA4HDRD2
Anisole SCHEMBL28273747 0.86 CA4 (0.74) CA4ALDH1A1RECQLLTA4HDRD2
Phenoxyethanol SCHEMBL28224596 0.85 ALDH1A1 (0.79) CA4ALDH1A1RECQLLTA4HDRD2
Diphenylether SCHEMBL15348001 0.85 ALDH1A1 (0.54) CA4ALDH1A1RECQLLTA4HTSHR
Anisole SCHEMBL28279032 0.84 CA4 (0.70) CA4ALDH1A1RECQLLTA4HDRD2
Anisole SCHEMBL27572996 0.84 CA4 (0.78) CA4ALDH1A1RECQLLTA4HDRD2
Di(Hydroxyethyl)Ether SCHEMBL1592391 0.83 LTA4H (0.56) ALDH1A1LTA4HTSHRMAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12419561-B2 Bio-electrode composition, bio-electrode, and method for manufacturing bio-electrode SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-09-23 US disclosed
EP-3995544-B1 BIO-ELECTRODE COMPOSITION, BIO-ELECTRODE, AND METHOD FOR MANUFACTURING BIO-ELECTRODE SHINETSU CHEMICAL CO (JP) 2024-12-04 EP disclosed
CN-114431864-B Bioelectrode composition, bioelectrode, and bioelectrode manufacturing method 信越化学工业株式会社 2024-12-03 CN disclosed
CN-110093063-B Magenta dye-based ink composition, ink set, and method for improving print quality of magenta dye-based ink composition 船井电机株式会社 2022-05-17 CN disclosed
EP-3995544-A1 BIO-ELECTRODE COMPOSITION, BIO-ELECTRODE, AND METHOD FOR MANUFACTURING BIO-ELECTRODE Shin-Etsu Chemical Co., Ltd. (JP) 2022-05-11 EP disclosed
CN-114431864-A Bioelectrode composition, bioelectrode, and method for producing bioelectrode 信越化学工业株式会社 2022-05-06 CN disclosed
US-20220133201-A1 BIO-ELECTRODE COMPOSITION, BIO-ELECTRODE, AND METHOD FOR MANUFACTURING BIO-ELECTRODE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2022-05-05 US disclosed
CN-102008729-A Composition for external use ROHTO PHARMA 2011-04-13 CN disclosed
CN-101102797-A External composition ROHTO PHARMA (JP) 2008-01-09 CN disclosed
US-20060263399-A1 Preparation for external use on skin VIVIER CANADA INC. (CA) 2006-11-23 US disclosed
EP-0735403-B1 Liquid crystal orienting agent JSR CORP (JP) 2004-03-17 EP disclosed
US-5700860-A Liquid crystal orienting agent JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1997-12-23 US disclosed
EP-0799180-A1 PROCESS FOR THE CARBONYLATION OF ETHYLENE AND CATALYST SYSTEM FOR USE THEREIN IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1997-10-08 EP disclosed
EP-0735403-A1 Liquid crystal orienting agent JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1996-10-02 EP disclosed
WO-1996019434-A1 PROCESS FOR THE CARBONYLATION OF ETHYLENE AND CATALYST SYSTEM FOR USE THEREIN IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1996-06-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060263399-A1 Preparation for external use on skin CUTA, SLC6A12, PROC CA4 1351/4885ALDH1A1 25/4885RECQL 1111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.